September 27 was a positive day for Prometic Life Sciences Inc. (PLI:CA) as its stock finished the day having gained 8.85% to hit a price of $14.15 a share. The company reached a market cap of 329.88 million and has 23.31 million shares outstanding. Prometic Life Sciences Inc. is a component of the the S&P/TSX Composite Index.
5,918 shares changed hands over the course of the day as compared to an average volume of n/a over the last 30 days for Prometic Life Sciences Inc..
Prometic Life Sciences Inc is a global biopharmaceutical corporation supplying technologies for Bioseparations while also developing its own orphan drugs, plasma-derived therapeutics and small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation and cancer. The company also offers drug purification of biologics, drug development, proteomics and the elimination of pathogens.. The company makes its home in Laval, QC, and is currently under the leadership of CEO Kenneth Galbraith.
Prometic Life Sciences Inc. has hit a high of $590.00 and reached a low of $7.13 over its last year of trading. The stock’s 50-day SMA is now $n/a and 200-day SMA is $n/a. As for its price valuations, the P/E ratio is at n/a and P/B is now 2.33.